<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">Prevalence of neurological complications were high among patients with MERS-CoV infection. In a study by Saad M et al. [
 <xref rid="bb0160" ref-type="bibr">32</xref>] 29 out of 70 patients with MERS-CoV infection had neurological manifestations. Serious neurological complications such as ischemic stroke and encephalitis were also reported in these patients. (
 <xref rid="t0010" ref-type="table">Table 2</xref> ) Some of these complications did not coexist with the respiratory symptoms and were delayed for approximately 2â€“3 weeks later. [
 <xref rid="bb0180" ref-type="bibr">36</xref>] Intracranial hemorrhage (ICH) was reported in 2 patients; in one, an abnormal coagulation panel and disseminated intravascular coagulation (DIC) were noted leading to severe multiple organ failure, but the other patient had a normal coagulation panel and platelet count. [
 <xref rid="bb0170" ref-type="bibr">34</xref>,
 <xref rid="bb0175" ref-type="bibr">35</xref>] Both patients were women and relatively young.
</p>
